<HTML><HEAD><META http-equiv="Content-type" content="text/html;charset=UTF-8"></HEAD><BODY><DIV><P><BR>                     <BR>                     <BR>                     Information for Patients (see Patient Package Insert) <BR>                     <BR>                        Patients and patients' caregivers should be informed of the expected adverse effects of XELODA, particularly nausea, vomiting, diarrhea, and hand-and-foot syndrome, and should be made aware that patient-specific dose adaptations during therapy are expected and necessary (see <BR>                              DOSAGE AND ADMINISTRATION<BR>                           ). Patients should be encouraged to recognize the common grade 2 toxicities associated with XELODA treatment.<BR>                     <BR>                  <BR>               </P></DIV></HTML>